证券代码：832471 证券简称：美邦科技 公告编号：2025-016 河北美邦工程科技股份有限公司 第四届董事会第九次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 29 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出董事会会议通知的时间和方式：2025 年 4 月 18 日以邮件方式发出 5.会议主持人：董事长高文杲 6.会议列席人员：监事会成员、董事会秘书及公司高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 本议案无需回避表决。 4.提交股东会表决情况： 本议案无需提交股东会审议。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于 2024 年度总经理工作报告的议案》 1.议案内容： 根据 ...

2024 年年度权益分派预案公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 证券代码：832471 证券简称：美邦科技 公告编号：2025-021 河北美邦工程科技股份有限公司 一、权益分派预案情况 根据公司 2025 年 4 月 29 日披露的 2024 年年度报告（财务报告已经审计）， 截至 2024 年 12 月 31 日，上市公司合并报表归属于母公司的未分配利润为 197,613,481.48 元，母公司未分配利润为 175,599,059.01 元。 公司本次权益分派预案如下：公司目前总股本为 83,200,000 股，根据扣除回 购专户 1,280,000 股后的 81,920,000 股为基数，以未分配利润向全体股东每 10 股 派发现金红利 1.00 元（含税）。本次权益分派共预计派发现金红利 8,192,000 元。 公司将以权益分派实施时股权登记日应分配股数为基数，如股权登记日应分 配股数与目前预计不一致的，公司将维持分派比例不变，并相应调整分派总额。 实际分派结果以中国证券登 ...

Regulatory and Industry Standards - The company participated in the formulation of the national mandatory standard for energy consumption limits in the refining industry, effective from May 1, 2025[4]. - The chemical industry is undergoing a transformation towards high-end, green, and digital development, driven by dual carbon goals and sustainable growth policies[49]. - Recent regulations emphasize the importance of green materials and sustainable practices in the chemical industry, with specific targets set for carbon neutrality and energy efficiency[181]. - The government is promoting the green transformation of traditional manufacturing sectors, including chemicals, to enhance sustainability[184]. Innovation and Research & Development - The company applied for 22 national patents during the reporting period, including 6 invention patents and 16 utility model patents, with 16 patents granted[12]. - The company is actively enhancing its R&D capabilities by attracting high-end scientific personnel to support long-term growth[48]. - The company achieved a research and development expenditure of ¥24,563,871.72, representing 4.55% of operating revenue, compared to ¥21,890,948.27 and 4.58% in the previous period[95]. - The total number of R&D personnel increased from 60 to 67, with the proportion of R&D staff to total employees rising from 17.44% to 18.26%[96]. - The company holds a total of 172 patents, up from 160 in the previous period, including 73 invention patents[97]. Financial Performance - The company’s operating revenue for 2024 was CNY 539,592,663.64, representing a 12.89% increase compared to CNY 477,980,447.37 in 2023[31]. - The net profit attributable to shareholders of the listed company was a loss of CNY 3,452,716.65, a decrease of 115.30% from a profit of CNY 22,569,060.74 in 2023[31]. - The total assets increased by 4.07% to CNY 992,769,159.24 at the end of 2024, compared to CNY 953,964,753.93 at the end of 2023[32]. - The total liabilities rose by 22.59% to CNY 348,225,654.41, up from CNY 284,055,763.20 in 2023[32]. - The gross profit margin for 2024 was 17.53%, slightly up from 17.05% in 2023[31]. Market Position and Strategy - The company is engaged in the research, production, and sales of green technology industrialized products, including tetrahydrofuran and toluene oxidation series products[25]. - The company’s annual production capacity for tetrahydrofuran is projected to reach 30,000 tons, which will increase its market share and position as the largest domestic producer using the LBDO purification method[50]. - The company is positioned within a tight industrial chain cluster, enhancing its competitive edge in the BDO industry[108]. - The company aims to deepen its main business in toluene oxidation series products and tetrahydrofuran, focusing on energy-saving expansion and cost reduction projects to enhance production capacity and economic efficiency[113]. Environmental and Compliance Efforts - The company is committed to sustainable development through the application of synthetic biology and green chemistry principles[111]. - The company maintains a strong focus on environmental protection and compliance with relevant laws and regulations[104]. - The company has implemented measures to address environmental protection risks associated with its production processes, ensuring compliance with pollution control standards[118]. Shareholder and Corporate Governance - The company has initiated a share repurchase plan with a total budget of 10,000,000 to 20,000,000 CNY, aiming to buy back between 781,250 and 1,562,500 shares, which is 0.94% to 1.88% of its total share capital[131]. - The company has successfully completed its share repurchase plan, acquiring 1,280,000 shares at an average price of 12.28 CNY per share, totaling 11,779,583.28 CNY[132]. - The company has established a comprehensive internal control system to enhance risk prevention capabilities and ensure compliance with relevant laws and regulations[115]. - The company has a total of 127,877,500.00 CNY in external guarantees, which accounts for a significant portion of its financial commitments[129]. Human Resources and Employee Development - The total number of employees increased from 344 to 367, with a net addition of 23 employees during the reporting period[171]. - A comprehensive training program has been implemented to improve employee skills and capabilities, including leadership training for mid-level managers and technical training for R&D personnel[174]. - The company has established a human resource planning system aligned with its strategic goals, focusing on competitive compensation and performance incentives to enhance employee motivation[173]. Legal and Risk Management - The company is currently involved in a lawsuit as a defendant, with a cumulative amount of 32,000,000 CNY, representing 4.96% of its net assets[124]. - The company has frozen bank account funds amounting to 32 million yuan due to legal disputes, but other funds in the account remain available for normal operations[137]. - The company has not identified any new major risk factors during the reporting period[120]. - The company has not experienced any significant changes in major risk factors during the reporting period[1].

Financial Performance - Operating revenue for the first quarter of 2025 was CNY 115,716,247.40, down 4.09% year-on-year[8] - Net profit attributable to shareholders for the first quarter of 2025 was a loss of CNY 746,900.07, representing a decline of 130.31% compared to the same period last year[8] - The weighted average return on equity based on net profit attributable to shareholders was -0.14% for the first quarter of 2025, down from 0.44% in the previous year[8] - Net profit for Q1 2025 was a loss of CNY 1,254,527.11, compared to a net profit of CNY 6,227,468.62 in Q1 2024, indicating a significant decline[35] - The total comprehensive income attributable to the parent company was -751,577.04 yuan, compared to 2,464,822.50 yuan in the previous year[36] - Basic and diluted earnings per share were both -0.01 yuan, down from 0.0296 yuan in the same period last year[36] Cash Flow - The net cash flow from operating activities decreased by 69.37% to CNY 3,921,241.83 compared to the previous year[8] - Net cash flow from operating activities amounted to $21,554,054.56, an increase from $16,301,051.07 in the previous period, representing a growth of approximately 32.8%[41] - Cash flow from financing activities generated a net inflow of 19,639,164.86 yuan, compared to a net outflow of -872,597.52 yuan in the previous year[39] - Cash inflow from investment activities was 145,335,639.40 yuan, compared to 10,178,018.58 yuan in the same period last year[39] - The ending balance of cash and cash equivalents was 89,970,075.71 yuan, up from 74,483,947.96 yuan in Q1 2024[39] - The net increase in cash and cash equivalents was -$1,169,509.08, compared to -$7,948,532.21 in the previous period, showing an improvement in cash management[41] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 981,346,351.43, a decrease of 1.15% compared to the end of the previous year[8] - The company's asset-liability ratio (consolidated) was 34.33%, a slight decrease from 35.08% at the end of the previous year[8] - Total liabilities decreased from CNY 348,225,654.41 to CNY 336,871,696.19, a reduction of approximately 3.9%[30] - Total current assets decreased from CNY 436,712,056.22 on December 31, 2024, to CNY 419,696,735.71 on March 31, 2025, a decline of approximately 3.7%[28] - Total non-current assets increased from CNY 556,057,103.02 to CNY 561,649,615.72, a growth of about 1.7%[29] Shareholder Information - The company has a total of 55,243,857 shares held by the top ten shareholders, representing 66.39% of the total shares[17] - The largest shareholder, Gao Wengao, holds 27.67% of the shares, with a total of 23,022,000 shares[16] Research and Development - Research and development expenses increased by 66.65% to CNY 7,696,788.65 due to increased investment in R&D[10] - Research and development expenses rose to CNY 7,696,788.65 in Q1 2025, up from CNY 4,618,555.66 in Q1 2024, reflecting an increase of approximately 66.8%[34] Financial Commitments and Guarantees - The company provided a guarantee for a bank credit limit of RMB 27,877,500 for its subsidiary, Hubei Kelin Bolun New Materials Co., Ltd.[21] - The company has pledged 65% of its equity in Ningxia Meibang Huanyu Chemical Co., Ltd. as collateral for a loan of RMB 100 million[21] - The company has a total of RMB 180,596,193.23 in assets under restriction, accounting for 18.40% of total assets[25] - The company has a frozen bank account with a total of RMB 32,000,000, which represents 3.26% of total assets[25] - The company has provided a guarantee for a credit limit of RMB 65 million for its subsidiary, with a guarantee amount of RMB 27,877,500[22] - The company has no significant risks or impacts from the pledged assets on its operations[24] Other Financial Metrics - Total operating costs increased to CNY 116,649,899.41 in Q1 2025 from CNY 112,933,484.89 in Q1 2024, marking an increase of about 3.0%[34] - The company reported a significant increase in financial expenses, with interest expenses rising to CNY 501,687.79 in Q1 2025 from CNY 647,062.37 in Q1 2024[34] - The company experienced a credit impairment loss of CNY -624,416.20 in Q1 2025, compared to CNY -1,128,501.04 in Q1 2024, indicating an improvement[35] - Other comprehensive income after tax for Q1 2025 was CNY -4,676.97, contrasting with CNY 738.03 in Q1 2024, showing a negative shift[35]

证券代码：832471 证券简称：美邦科技 公告编号：2025-015 河北美邦工程科技股份有限公司 简式权益变动报告书 信息披露义务人及其主要负责人保证公告内容的真实、准确和完整，不存在 虚假记载、误导性陈述或者重大遗漏。 信息披露义务人保证除本报告书披露的信息外，没有通过任何其他方式增加 或减少其在上市公司中拥有权益的股份。 上市公司名称：河北美邦工程科技股份有限公司 股票上市地点：北京证券交易所 股票简称：美邦科技 股票代码：832471 信息披露义务人一：高文杲 住所和通讯地址：河北省石家庄市****** 信息披露义务人二：张玉新 住所和通讯地址：河北省石家庄市****** 信息披露义务人三：金作宏 住所和通讯地址：河北省石家庄市****** 信息披露义务人五：张卫国 住所和通讯地址：河北省石家庄市****** 信息披露义务人六：付海杰 住所和通讯地址：河北省石家庄市****** 信息披露义务人七：马记 住所和通讯地址：河北省石家庄市****** 权益变动性质： 持股比例下降 信息披露义务人声明 一、本报告书系信息披露义务人根据《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司收购管理办法》 ...

证券代码：832471 证券简称：美邦科技 公告编号：2025-014 河北美邦工程科技股份有限公司实际控制人及其一致行动人变更 公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、变更基本情况 （一）变更主体 | □第一大股东变更 | □控股股东变更 | | --- | --- | | √实际控制人变更 | √一致行动人变更 | （二）变更方式 穆英通过继承刘东的股份，使得上市公司实际控制人及其一致行动人由高文杲、张玉 新、金作宏、张利岗、张卫国、付海杰、刘东、马记减少为高文杲、张玉新、金作宏、张 利岗、张卫国、付海杰、马记，不存在新增的一致行动人。 二、变更后实际控制人及其一致行动人基本情况 （一）自然人填写 | 姓名 | 高文杲 | | --- | --- | | 国籍 | 中国 | | 是否拥有永久境外居留权 | 否 | | 最近五年内的工作单位及职务 | 河北美邦工程科技股份有限公司董事长、总经理 | | 现任职单位主要业务 | 化工新材料、生物健康领域绿色制造技术的研 | | | 发、 ...

中国国际金融股份有限公司 一、本次担保的基本情况 公司控股子公司湖北科林博伦新材料有限公司（以下简称"科林博伦"）于 2023 年向武汉农村商业银行股份有限公司宜昌分行申请的贷款即将到期，为满 足经营和业务发展需要，拟向武汉农村商业银行股份有限公司宜昌分行继续申请 综合授信额度人民币 6,500 万元，其中敞口额度 4,500 万元，授信期限不超过 3 年（含 3 年）。公司为上述敞口额度提供连带责任保证担保，担保金额人民币 2,787.75 万元，具体担保金额、担保方式及担保期限以后续签订的担保合同为准。 二、本次担保履行的审批程序 关于河北美邦工程科技股份有限公司 2025 年 3 月 5 日，公司召开第四届董事会第八次会议，审议通过了《关于 为子公司提供担保的议案》，同意公司为控股子公司科林博伦向银行申请不超过 人民币 6,500 万元（含 6,500 万元）综合授信额度中 4,500 万元的敞口额度提供 担保。公司一年内累计对外担保金额占公司最近一期经审计总资产的 16.33%， 占公司最近一期经审计净资产的 23.25%，该议案在董事会审批权限范围内，无 需提交公司股东大会审议。 提供担保的核查意见 ...

一、担保情况概述 （一）担保基本情况 证券代码：832471 证券简称：美邦科技 公告编号：2025-012 河北美邦工程科技股份有限公司 提供担保的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 公司控股子公司湖北科林博伦新材料有限公司（以下简称"科林博伦"） 于 2023 年向武汉农村商业银行股份有限公司宜昌分行申请的贷款即将到期， 为满足经营和业务发展需要，拟向武汉农村商业银行股份有限公司宜昌分行继 续申请综合授信额度人民币 6,500 万元，其中敞口额度 4,500 万元，授信期限 不超过 3 年（含 3 年）。公司为上述敞口额度提供连带责任保证担保，担保金 额人民币 2,787.75 万元，具体担保金额、担保方式及担保期限以后续签订的担 保合同为准。 （二）是否构成关联交易 本次交易不构成关联交易。 （三）决策与审议程序 公司于 2025 年 3 月 5 日召开第四届董事会第八次会议，审议通过《关于 为子公司提供担保的议案》。 议案表决结果为：同意 7 票；反对 0 票；弃权 0 票。 ...

证券代码：832471 证券简称：美邦科技 公告编号：2025-011 河北美邦工程科技股份有限公司 第四届董事会第八次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 3 月 5 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出董事会会议通知的时间和方式：2025 年 2 月 28 日以邮件方式发出 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于为子公司提供担保的议案》 1.议案内容： 具体内容详见公司在北京证券交易所信息披露平台(www.bse.cn)上披露 的《提供担保的公告》（公告编号：2025-012）。 5.会议主持人：董事长高文杲 6.会议列席人员：董事会秘书及公司高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 ...

Financial Performance - The company's operating revenue for the reporting period reached ¥539,732,616.19, representing a year-on-year increase of 12.92%[4] - The net profit attributable to shareholders decreased by 71.51% to ¥6,430,753.38 compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 84.92% to ¥2,206,078.86[4] - Basic earnings per share decreased by 72.41% to ¥0.08[4] Assets and Equity - Total assets at the end of the reporting period amounted to ¥997,831,415.35, an increase of 4.60% from the beginning of the period[4] - Shareholders' equity attributable to the company decreased by 1.84% to ¥547,604,293.22[4] Operational Challenges - The decline in net profit was primarily due to the suspension of a 10,000 tons/year tetrahydrofuran production line and planned upgrades to a 300 tons/year catalyst production line, leading to an asset impairment provision of approximately ¥27 million[5] - The increase in operating revenue was attributed to improved production management and increased output of fine chemical products[5] Dividends and Share Repurchases - Cash dividends paid during the reporting period amounted to ¥8,213,000, and share repurchases totaled ¥10,975,900[5] Cautionary Note - The company emphasizes that the financial data is preliminary and unaudited, urging investors to be cautious[6]